Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Testing effectiveness (Phase 2)Study completedNCT02931071
What this trial is testing

Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1

Who this might be right for
Fanconi Anemia
Hospital Universitari Vall d'Hebron Research Institute 13
Testing effectiveness (Phase 2)Study completedNCT00066092
What this trial is testing

Pegfilgrastim PBPC Mobilization Study

Who this might be right for
LymphomaHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more
Amgen 41
Testing effectiveness (Phase 2)Ended earlyNCT01182675
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 7
Testing effectiveness (Phase 2)Study completedNCT01097057
What this trial is testing

Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells

Who this might be right for
Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center 20
Not applicableLooking for participantsNCT00001529
What this trial is testing

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Who this might be right for
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI) 500
Not applicableNot Yet RecruitingNCT07423728
What this trial is testing

CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors

Who this might be right for
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
First Affiliated Hospital of Zhejiang University 160
Testing effectiveness (Phase 2)Study completedNCT03993639
What this trial is testing

KRN125 for Mobilization of Hematopoietic Stem Cells

Who this might be right for
Peripheral Blood Stem Cell Transplantation
Kyowa Kirin Co., Ltd. 35
Testing effectiveness (Phase 2)Study completedNCT00025545
What this trial is testing

Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05421416
What this trial is testing

Loratadine for the Prevention of G-CSF-related Bone Pain

Who this might be right for
Stem Cell Transplant Complications
AHS Cancer Control Alberta 78
Testing effectiveness (Phase 2)Ended earlyNCT01016795
What this trial is testing

Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma

Who this might be right for
Malignant Lymphoma
Aalborg University Hospital 32
Not applicableStudy completedNCT00001071
What this trial is testing

Stem Cells and Filgrastim

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00082329
What this trial is testing

G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers

Who this might be right for
Healthy
National Heart, Lung, and Blood Institute (NHLBI) 9
Large-scale testing (Phase 3)Ended earlyNCT03029000
What this trial is testing

Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants

Who this might be right for
Healthy Participants
Teva Branded Pharmaceutical Products R&D, Inc. 1
Not applicableWithdrawnNCT00006578
What this trial is testing

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00117455
What this trial is testing

Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen
Not applicableStudy completedNCT00511550
What this trial is testing

Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors

Who this might be right for
Healthy
University of California, San Francisco 15
Early research (Phase 1)Study completedNCT01026987
What this trial is testing

Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant

Who this might be right for
Stem Cell Transplant Patients
Washington University School of Medicine 29
Large-scale testing (Phase 3)Study completedNCT00005782
What this trial is testing

Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait

Who this might be right for
Sickle Cell Trait
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Large-scale testing (Phase 3)Active Not RecruitingNCT03246529
What this trial is testing

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
BioLineRx, Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT02078102
What this trial is testing

A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Sherif S. Farag 38
Load More Results